Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST).

"Disclosure M.G.R. has received research and education grants from Intuitive Surgical and Medtronic; and consultancy fees from Intuitive Surgical, Medtronic, and Johnson & Johnson. Tero Rautio, Philippe Rouanet, Jim Khan, and Paolo Bianchi have received consultancy fees from Intuitive Surgical. The authors declare no other conflict of interest."

"Funding The MIRCAST Study Group has received research intensification grants from the Regional Government of Cantabria, Spain, and a research grant from Intuitive Surgical (Sunnyvale, CA, USA). MIRCAST was designed and conducted independently at the Valdecilla Biomedical Research Institute (IDIVAL). The funding institutions had no influence in the design or conduct of the study."

"This international, multicentre, prospective, observational, non-randomized, parallel, four-cohort study was performed according to a published protocol. The study was supported by the European Society of Coloproctology and given advice by a steering committee of expert surgeons. The study received approval from all ethical boards across participant centres in Europe and followed the principles outlined in the Declaration of Helsinki. The study was registered at ClinicalTrials.gov (NCT03650517) on 28 August 2018 (study protocol version CI18/02 revision A, 21 February 2018). The protocol was modified in May 2020 after an interim analysis (study protocol version CI18/27, 14 May 2020)."